Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions

Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions
Conditions:   Erythroplakia;   Leukoplakia;   Oral Cavity Carcinoma;   Proliferative Verrucous Leukoplakia
Interventions:   Drug: Metformin;   Procedure: Biopsy
Sponsors:   Thomas Jefferson University;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 11, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments